Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptomsMichael J. Peluso, Timothy J. Henrich, Joanna Donatelli et al.|Cell Reports|2021Cited by 266
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological ManifestationsBing Sun, Lynn Pulliam, Norina Tang et al.|Cells|2021Cited by 187
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J. Peluso, Bryan Greenhouse, Saki Takahashi et al.|Science Advances|2021Cited by 150